icd 9 code for small cell lung cancer with brain mets

Ngày tải lên: 13/08/2014, 16:21

... advanced non -small- cell lung cancer: a phase III trial of the European Organiza- tion for Research and Treatment of Cancer Lung Cancer Group – EORTC 0 897 5. J Clin Oncol 2003, 21: 390 9- 391 7. 15. Gasperi-Campani ... cisplatin-teniposide in patients with advanced non -small- cell lung cancer. The European Organi- zation for Research and Treatment of Cancer Lung Cancer Cooperative Group. J Clin Oncol 199 8, 16:2133-2141. 7. ... Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001, 94 :153-156. 2. Non -small Cell Lung Cancer Collaborative Group: Chemotherapy in non small cell lung cancer: a meta-analysis...

Ngày tải lên: 18/06/2014, 15:20

... <0.0001 Progressive -0.1 798 0.021 69 99 -8. 29 <0.0001 Response 0.0 193 0.006556 99 2 .94 0.004 Stable 0 . . . . Neutropenia -0.0 897 3 0.01543 99 -5.82 <0.0001 Febrile Neutropenia -0. 090 02 0.01633 99 -5.51 <0.0001 Fatigue ... 0.018 49 99 -3 .97 0.0001 Nausea & vomiting -0.04802 0.01618 99 -2 .97 0.0038 Diarrhoea -0.0468 0.01553 99 -3.01 0.0033 Hair loss -0.04 495 0.01482 99 -3.03 0.0031 Rash -0.03248 0.01171 99 -2.77 ... Staging of small cell and non -small cell lung cancer. University of Iowa Virtual Hos- pital; 199 9. 6. Hopwood P, Stephens RJ: Symptoms at presentation for treat- ment in patients with lung cancer: ...

Ngày tải lên: 18/06/2014, 19:20

... CA: Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non -small cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 199 9, 45:323-3 29. 25. Kwa SL, Lebesque JV, Theuws JC, ... was 79% for 85 stage IA patients treated with 48 Gy and 56% for 37 stage IB patients treated with 52 Gy (p = 0.05). At 3 years, cause-specific survival was 91 % for the former group and 79% for ... non -small- cell lung cancer: clinical implications. Radiother Oncol 2010, 94 :1-11. 27. Chen Y, Guo W, Lu Y, Zou B: Dose-individualized stereotactic body radiotherapy for T1-3N0 non -small cell lung...

Ngày tải lên: 09/08/2014, 09:20

... body radiotherapy for stage I non -small cell lung cancer. Radiother Oncol 2007, 85:4 29- 434. 39. Sinha B, McGarry RC: Stereotactic body radiotherapy for bilat- eral primary lung cancers: the Indiana ... treatment options for stage I non -small cell lung cancer. Oncologist 2008, 13:3 09- 3 19. 41. Brock J, Ashley S, Bedford J, Nioutsikou E, Partridge M, Brada M: Review of Hypofractionated Small Volume ... non -small cell Lung cancer (ROSEL, ClinicalTrials.gov ID = NCT0068 798 6) has been opened for accrual in August 2008. The study is initiated by the VU medical centre Amsterdam and the Dutch Lung Cancer...

Ngày tải lên: 09/08/2014, 09:22

... To evaluate the performance of surface-based deformable image registration (DR) for adaptive radiotherapy of non -small cell lung cancer (NSCLC). Methods: Based on 13 patients with locally advanced ... radiotherapy for head-and-neck cancer using an integrated CT/linear accelerator system. Int J Radiat Oncol Biol Phys 2004, 59: 960 -97 0. 9. Kupelian PA, Ramsey C, Meeks SL, Willough TR, Forbes A, ... was performed for evalua- tion of the DR accuracy. Residual errors after DR were small at the GTV surface with 3D errors of 2 .9 mm on average. Larger residual errors after DR were measured for intrapulmonary...

Ngày tải lên: 09/08/2014, 10:20

Ngày tải lên: 09/08/2014, 10:21

Ngày tải lên: 10/08/2014, 09:22

Ngày tải lên: 10/08/2014, 10:21

Ngày tải lên: 10/08/2014, 22:20

Ngày tải lên: 10/08/2014, 22:20

Ngày tải lên: 14/08/2014, 19:22

... sensitivity overall 92 % delE746-A750 Ab 63% 22.86% 81.1% 99 % 84.6% 79% l858r Ab 100% 75% 97 % 95 .2% 83% IHC specificity overall 99 % delE746-A750 Ab 100% 92 % 100% 40% 98 .8% L858R Ab 100% 96 .6% 36% 98 .8% Simonetti ... inactivated at 95 °C for 10 min, and the cell extract submitted to PCR. DNA from the cell line PC -9 was used as a mutated control for exon 19, and wt control for exons 20 and 21. DNA from the H 197 5 cell ... Non -small- cell lung cancer harbouring mutations in the EGFR kinase domain. Clin Transl Oncol 2010, 12:75-80. 9. Gazdar AF: Activating and resistance mutations of EGFR in non -small- cell lung cancer: ...

Ngày tải lên: 18/06/2014, 16:20

... and for clinical-pathological reasons are often divided into two broad categories: small cell lung cancer (SCLC) and non -small cell lung cancer (NSCLC). All major histological types of lung cancer ... as a risk marker of lung cancer in Taiwan. Cancer 2003, 97 :1558-1563. 11. Klein F, Amin Kotb WF, Petersen I: Incidence of human papilloma virus in lung cancer. Lung Cancer 20 09, 65:13-18. 12. Zochbauer-Muller ... A primary xenograft model of small- cell lung cancer reveals irreversible changes in gene expression imposed by culture in vitro. Cancer Res 20 09, 69( 8):3364-3373. 19. Schaffer BE, Park KS, Yiu...

Ngày tải lên: 18/06/2014, 16:20

... 48 190 59 High 158 47 84 58 Missing 15 5 SCC (n = 191 ) NS Low 89 47 133 64 0.88 High 98 51 120 68 Missing 4 2 SCC, N0 0.15 NS Low 59 47 160 79 High 68 53 1 29 67 SCC, N+ 0.034 Low 30 50 49 32 High ... patients treated with adjuvant chemotherapy after complete resection of non -small cell lung carcinoma. Cancer Res 2010, 70:8288 -98 . 19. Goldstraw P: The 7th Edition of TNM in Lung Cancer: what now? ... 20 09, 14:253-63. 23. Donnem T, Al-Saad S, Al-Shibli K, et al: Inverse prognostic impact of angiogenic marker expression in tumor cells versus stromal cells in non small cell lung cancer. Clin Cancer...

Ngày tải lên: 18/06/2014, 16:20

... ZD18 39) in non -small- cell lung can- cer. Br J Cancer. 2004; 91 (2): 208-12. 89. Bailey R, Kris M, Wolf M. Gefitinib (Iressa, ZD 18 39) mono- therapy for pretreated advanced non -small cell lung cancer ... 18(6): 10 59- 68. 3. Travis WD, Travis LB, Devesa SS. Lung cancer. Cancer. 199 5; 75(1 Suppl): 191 -202. 4. Franceschi S, Bidoli E. The epidemiology of lung cancer. Ann Oncol. 199 9; 10 (Suppl ... in non -small cell lung cancer Is correlated with survival. Clin Cancer Res. 2001; 7(7): 1850-5. 93 . Cappuzzo F, Gregorc V, Rossi E, et al. Gefitinib in pretreated non -small- cell lung cancer...

Ngày tải lên: 08/08/2014, 17:20

... Carteni’ 1 Abstract Background: Defining the optimal treatment for patients with inoperable non small cell lung cancer (NSCLC), presenting with metastatic mediastinal lymph nodes, is challenging. Nevertheless, ... treatment. Introduction In non -small cell lung cancer (NSCLC), mediastinal lymphnode involvement comprises a wide spectrum of severity. In fact, while 9% of patients with IIIA-N2 NSCLC is candidate for surgery ... Access Pathological complete response induced by first-line chemotherapy with single agent docetaxel in a patient with advanced non small cell lung cancer Ferdinando Riccardi 1* , Giuseppe Di Lorenzo 1 , Carlo...

Ngày tải lên: 09/08/2014, 03:21

... thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non -small- cell lung cancer. J Clin Oncol 199 9, 17:2 692 -2 699 . 3. Komaki R, Seiferheld W, Curran ... stage small cell lung cancer. Int J Radiat Oncol Biol Phys 199 9, 43: 39- 45. 31. Rancati T, Ceresoli GL, Gagliardi G, Schipani S, Cattaneo GM: Factors predicting radiation pneumonitis in lung cancer ... Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non -small cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 199 9, 45:323-3 29. 15. Tsujino K, Hirota S, Endo M,...

Ngày tải lên: 09/08/2014, 08:23

... Johnson DH: Twice-daily compared with once-daily thoracic radiotherapy in limited small- cell lung cancer treated concurrently with cisplatin and etoposide. N Engl J Med 199 9, 340:265-271. 4. Miller ... is feasible concurrent with chemotherapy for limited-stage small- cell lung cancer: analysis of Cancer and Leukemia Group B study 398 08. Int J Radiat Oncol Biol Phys 2004, 59: 460-468. 7. Miller ... the two groups. The median OS for patients treated with low BED and those with high BED were 16.4 months (95 % CI, 10 .9- 21 .9 months) and 25.4 months (95 %CI, 21 .9- 29. 0 months); 2- and 5-year OS...

Ngày tải lên: 09/08/2014, 09:20

... iotherapy, Oligometastases, Non -Small Cell Lung Cancer Background Non -small cell lung cancer (NSCLC) is the leading cause of cancer mortality in the United States [1]. Patients with stage IV NSCLC typically ... for metastatic non small cell lung cancer (NSCLC) includes palliative systemic chemotherapy and/or radiotherapy. Recent studies of patients with limited metastases treated with curative-intent stereotactic ... expanding experience with stereo- tactic radiotherapy as effective local therapy for meta- static lesions from any primary cancer. Local control rates of 60 -90 % have been reported for metastatic tumors...

Ngày tải lên: 09/08/2014, 09:20